WJ-39 | MedChemExpress (MCE)
WJ-39 is an orally active aldose reductase (AR) inhibitor. WJ-39 improves tubular damage in diabetic nephropathy rats by activating PINK1/Parkin signaling, promoting mitophagy, and attenuating apoptosis[1].
| Trivial name | WJ-39 |
| Catalog Number | HY-162325 |
| Research Area | Metabolic Disease |
| CAS# | 3009908-95-3 |
| Purity | ≥98.0% |
| SMILES | COC1=CC=C(N(CC(O[K])=O)C=C(CC2=CC=CC(Cl)=C2Cl)C3=O)C3=C1 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/wj-39.html |